Top Genomics And Proteomics Stories


Comment & Analysis »

Pharma Technology Focus – Issue 50

In this issue: Maximising investment by cancer megafunds, positive clinical trials for an antibody to treat lupus, how copper can be used to tackle obesity, whether day and night should...

Pharma Technology Focus – Issue 50

July's top stories: GBT's Phase II1 trial GBT440, Merck's Phase III trial ONCEMRK of Isentress

July's top stories: GBT's Phase II1 trial GBT440, Merck's Phase III trial ONCEMRK of Isentress
 

June's top stories: Bayer reported positive results of RESORCE trial, TapImmune initiated Phase II trial of TPIV 200

June's top stories: Bayer reported positive results of RESORCE trial, TapImmune initiated Phase II trial of TPIV 200

May's top stories: ProMedica began human stem cell trial, Cerulean dosed in Phase l/ll combination trial

May's top stories: ProMedica began human stem cell trial, Cerulean dosed in Phase l/ll combination trial
 

April's top stories: SynbiCITE's synthetic biology foundry, Omeros's phase II clinical trial of OMS721

April's top stories: SynbiCITE's synthetic biology foundry, Omeros's phase II clinical trial of OMS721

Company Releases »

ePAT Automated Lab Reactor Optimised for 24/7 Data Capture

SYSTAG Systems Technik
ePAT Automated Lab Reactor Optimised for 24/7 Data Capture

Optimising Development Resources for Efficient Product Development

SYSTAG Systems Technik
Optimising Development Resources for Efficient Product Development

Validated Metal Analysis

Pfanstiehl Validated Metal Analysis

Benefits of Trehalose

Pfanstiehl
Benefits of Trehalose

Automation Systems for Small-Molecule Drug and API Development

SYSTAG Systems Technik Automation Systems for Small-Molecule Drug and API Development

Genomics And Proteomics Insights »

Companies »